CoChat

Gastroparesis: a turning point in understanding and treatment

Open access

The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.

Abstract

Gastroparesis is defined by delayed gastric emptying (GE) and symptoms of nausea, vomiting, bloating, postprandial fullness, early satiety and abdominal pain. Most common aetiologies include diabetes, postsurgical and postinfectious, but in many cases it is idiopathic. Clinical presentation and natural history vary by the aetiology. There is significant morbidity and healthcare utilisation associated with gastroparesis. Mechanistic studies from diabetic animal models of delayed GE as well as human full-thickness biopsies have significantly advanced our understanding of this disorder. An innate immune dysregulation and injury to the interstitial cells of Cajal and other components of the enteric nervous system through paracrine and oxidative stress mediators is likely central to the pathogenesis of gastroparesis. Scintigraphy and 13 C breath testing provide the most validated assessment of GE. The stagnant gastroparesis therapeutic landscape is likely to soon see significant changes. Relatively newer treatment strategies include antiemetics (aprepitant), prokinetics (prucalopride, relamorelin) and fundic relaxants (acotiamide, buspirone). Endoscopic pyloromyotomy appears promising over the short term, especially for symptoms of nausea and vomiting. Further controlled trials and identification of the appropriate subgroup with pyloric dysfunction and assessment of long-term outcomes are essential. This review highlights the clinical presentation, diagnosis, mechanisms and treatment advancements for gastroparesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2019-318712

Cites

158 of 158 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 158 references

Research works printed but not linked: 2

  1. 10.1111/j.1572-0241.2003.07389.x · doi:10.1111/j.1572-0241.2003.07389.x · Paper page
  2. 10.1111/j.1572-0241.2000.02076.x · doi:10.1111/j.1572-0241.2000.02076.x · Paper page

Cited by

See all 275

Metadata

Authors
Grover, M., Farrugia, G., & Stanghellini, V.
Affiliations
  • Mayo Clinic (US)
  • University of Bologna (IT)
Corresponding author
Grover, Madhusudan
Venue
Gut
Publisher
BMJ
Published
2019-09-28
Volume
68
Issue
12
Pages
2238-2250
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2975756653
Cited by
256
References
158
Citations by year
2026: 28 · 2025: 32 · 2024: 53 · 2023: 45 · 2022: 33 · 2021: 44 · 2020: 18
FWCI
4.30
Type
journal article
Language
en
Open access
Locations
  • Gut (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (DK057061, DK068055, DK74008, K23 DK103911)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
  • Health Sciences › Medicine › Surgery › Enhanced Recovery After Surgery
Keywords
gastroparesis, delayed gastric emptying, diabetes mellitus, idiopathic gastroparesis, postoperative gastroparesis, innate immune dysregulation, interstitial cells of Cajal, enteric nervous system, oxidative stress, scintigraphy, 13C breath test, prokinetic agents, acotiamide, buspirone, aprepitant, endoscopic pyloromyotomy, pyloric dysfunction, nausea and vomiting
MeSH terms
Gastric Emptying, Gastrointestinal Agents, Humans, Endoscopy, Gastrointestinal, Gastroparesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gastroparesis: a turning point in understanding and treatment. https://app.cochat.ai/papers/10.1136/gutjnl-2019-318712
The paper
Grover, M., Farrugia, G., & Stanghellini, V. (2019). Gastroparesis: a turning point in understanding and treatment. Gut. https://doi.org/10.1136/gutjnl-2019-318712

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.